Literature DB >> 20007718

Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration.

Matthew J Elrick1, Chris D Pacheco, Ting Yu, Nahid Dadgar, Vikram G Shakkottai, Christopher Ware, Henry L Paulson, Andrew P Lieberman.   

Abstract

Pathways regulating neuronal vulnerability are poorly understood, yet are central to identifying therapeutic targets for degenerative neurological diseases. Here, we characterize mechanisms underlying neurodegeneration in Niemann-Pick type C (NPC) disease, a lysosomal storage disorder characterized by impaired cholesterol trafficking. To date, the relative contributions of neuronal and glial defects to neuron loss are poorly defined. Using gene targeting, we generate Npc1 conditional null mutant mice. Deletion of Npc1 in mature cerebellar Purkinje cells leads to an age-dependent impairment in motor tasks, including rotarod and balance beam performance. Surprisingly, these mice did not show the early death or weight loss that are characteristic of global Npc1 null mice, suggesting that Purkinje cell degeneration does not underlie these phenotypes. Histological examination revealed the progressive loss of Purkinje cells in an anterior-to-posterior gradient. This cell autonomous neurodegeneration occurs in a spatiotemporal pattern similar to that of global knockout mice. A subpopulation of Purkinje cells in the posterior cerebellum exhibits marked resistance to cell death despite Npc1 deletion. To explore this selective response, we investigated the electrophysiological properties of vulnerable and susceptible Purkinje cell subpopulations. Unexpectedly, Purkinje cells in both subpopulations displayed no electrophysiological abnormalities prior to degeneration. Our data establish that Npc1 deficiency leads to cell autonomous, selective neurodegeneration and suggest that the ataxic symptoms of NPC disease arise from Purkinje cell death rather than cellular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007718      PMCID: PMC2816612          DOI: 10.1093/hmg/ddp552

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.

Authors:  Xiaofeng Gu; Chenjian Li; Weizheng Wei; Victor Lo; Shiaoching Gong; Shi-Hua Li; Takuji Iwasato; Shigeyoshi Itohara; Xiao-Jiang Li; Istvan Mody; Nathaniel Heintz; X William Yang
Journal:  Neuron       Date:  2005-05-05       Impact factor: 17.173

Review 2.  Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease.

Authors:  Christian S Lobsiger; Don W Cleveland
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

3.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.

Authors:  O Zhuchenko; J Bailey; P Bonnen; T Ashizawa; D W Stockton; C Amos; W B Dobyns; S H Subramony; H Y Zoghbi; C C Lee
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

4.  Hyperpolarizing current of the Na/K ATPase contributes to the membrane polarization of the Purkinje cell in rat cerebellum.

Authors:  S Genet; R T Kado
Journal:  Pflugers Arch       Date:  1997-09       Impact factor: 3.657

5.  Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease.

Authors:  Mary Y Heng; Sara J Tallaksen-Greene; Peter J Detloff; Roger L Albin
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

Review 6.  Niemann-Pick disease type C.

Authors:  M T Vanier; G Millat
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

Review 7.  Before the loss: neuronal dysfunction in Niemann-Pick Type C disease.

Authors:  Colleen A Paul; Aimee K Boegle; Robert A Maue
Journal:  Biochim Biophys Acta       Date:  2004-10-11

8.  Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1-/- mice.

Authors:  Min Zhang; Diana Strnatka; Carolyn Donohue; Janice L Hallows; Inez Vincent; Robert P Erickson
Journal:  J Neurosci Res       Date:  2008-10       Impact factor: 4.164

9.  Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.

Authors:  Anne McMahon; Stephen C Fowler; Teresa M Perney; Walther Akemann; Thomas Knöpfel; Rolf H Joho
Journal:  Eur J Neurosci       Date:  2004-06       Impact factor: 3.386

10.  Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.

Authors:  Cristin D Davidson; Nafeeza F Ali; Matthew C Micsenyi; Gloria Stephney; Sophie Renault; Kostantin Dobrenis; Daniel S Ory; Marie T Vanier; Steven U Walkley
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more
  66 in total

1.  Characterization of the Subventricular-Thalamo-Cortical Circuit in the NP-C Mouse Brain, and New Insights Regarding Treatment.

Authors:  Min Hee Park; Byung Jo Choi; Min Seock Jeong; Ju Youn Lee; In Kyung Jung; Kang Ho Park; Hye Won Lee; Tomoyuki Yamaguchi; Hugo H Marti; Beom Hee Lee; Edward H Schuchman; Hee Kyung Jin; Jae-Sung Bae
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

2.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

3.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

4.  Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.

Authors:  Chan Chung; Prasanth Puthanveetil; Daniel S Ory; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2016-01-28       Impact factor: 6.150

5.  Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.

Authors:  Colleen A Stoyas; David D Bushart; Pawel M Switonski; Jacqueline M Ward; Akshay Alaghatta; Mi-Bo Tang; Chenchen Niu; Mandheer Wadhwa; Haoran Huang; Alex Savchenko; Karim Gariani; Fang Xie; Joseph R Delaney; Terry Gaasterland; Johan Auwerx; Vikram G Shakkottai; Albert R La Spada
Journal:  Neuron       Date:  2019-12-16       Impact factor: 17.173

6.  Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling.

Authors:  Anastasia G Efthymiou; Joe Steiner; William J Pavan; Stephen Wincovitch; Denise M Larson; Forbes D Porter; Mahendra S Rao; Nasir Malik
Journal:  Stem Cells Transl Med       Date:  2015-01-30       Impact factor: 6.940

Review 7.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

8.  Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.

Authors:  Randy J Chandler; Ian M Williams; Alana L Gibson; Cristin D Davidson; Arturo A Incao; Brandon T Hubbard; Forbes D Porter; William J Pavan; Charles P Venditti
Journal:  Hum Mol Genet       Date:  2017-01-01       Impact factor: 6.150

9.  Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder.

Authors:  Chiara Di Malta; John D Fryer; Carmine Settembre; Andrea Ballabio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

10.  Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.

Authors:  Celine V M Cluzeau; Dawn E Watkins-Chow; Rao Fu; Bhavesh Borate; Nicole Yanjanin; Michelle K Dail; Cristin D Davidson; Steven U Walkley; Daniel S Ory; Christopher A Wassif; William J Pavan; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2012-05-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.